Keyphrases
Peritoneal Surface Malignancy
82%
Chicago
76%
In Cancer
44%
Surgical Oncologist
42%
Mutant p53
41%
Medical Oncologist
40%
Appropriate Management
39%
Peritoneal Surface Disease
39%
Palliative Care Physicians
37%
Pathologist
37%
Radiologists
37%
Enhanced Awareness
37%
Pharmacist
37%
Zinc Metallochaperones
34%
Tumor
31%
Appropriate Use Criteria
30%
Cancer Patients
30%
Zinc
28%
Small Molecules
25%
Nutrition Support
25%
Radium
25%
Liver
23%
Adjuvant Therapy
22%
Chemoradiation Therapy
21%
Hepatocellular Carcinoma
21%
Doxorubicin
20%
Metastatic Colorectal Cancer (mCRC)
19%
Resection
19%
Overall Survival
19%
Peritoneal Mesothelioma
18%
Chemotherapy
17%
Preoperative Chemotherapy
17%
Colorectal Cancer
16%
Liver Resection
16%
Radioembolization
15%
Fluid Administration
15%
Pancreaticoduodenectomy
15%
Difference Mapping
15%
Slope Difference
15%
Outcomes Research
15%
Extrahepatic Disease
15%
Malignant Peritoneal Mesothelioma
15%
Radiation Therapy
14%
Metabolism
13%
Gemcitabine
12%
Systemic Therapy
12%
Metastatic Pancreatic Ductal Adenocarcinoma
11%
Clinical nutrition
11%
Breast
11%
Expert Panel
11%
Surgical Therapy
11%
Adjuvant Chemoradiation
11%
Liver Metastasis
10%
Yttrium-90 Radioembolization
10%
Single Center
10%
Adjuvant Chemotherapy
10%
Ileal Neuroendocrine Tumors
10%
Thoracoscopic Esophagectomy
10%
Intraoperative Fluid
10%
Gastrointestinal Stromal Tumor
10%
Neuroendocrine Tumor
10%
Personalized nutrition
10%
Ovarian Neoplasms
10%
Conditional Survival
10%
Desmoplastic Small Round Cell Tumor (DSRCT)
10%
Clinical Practice Guidelines
10%
Appendiceal Neoplasms
10%
Peritoneal Metastasis
10%
Consensus Guidelines
10%
Hepatic Perfusion
10%
Left Hepatic Artery
10%
Executive Summary
10%
Confidence Interval
10%
Neoadjuvant
10%
Malignancy
9%
Neoadjuvant Therapy
9%
Treatment Strategy
9%
Surgery Alone
9%
Wild-type p53
9%
Local Therapy
8%
Hepatic Venous
8%
Clinical Trials
8%
DNA-binding Domain
8%
Pancreatic Cancer
7%
Regional Chemotherapy
7%
Parenteral nutrition
7%
Prostaglandin E2
7%
Liver-directed Therapy
7%
Gynecologic Oncologist
7%
Zn2+
7%
Mastectomy
7%
Treatment Options
7%
Esophageal Cancer
7%
Neoadjuvant Chemotherapy
7%
Common Hepatic Artery
7%
Clinical Scenarios
7%
Gastrointestinal Surgery
7%
Patient Selection
7%
Drug-drug Interaction Extraction
7%
Breast Reconstruction
7%
Cancer Tumor
7%
Light Signaling
7%
Pancreatic Adenocarcinoma
7%
Zinc Binding
7%
Hepatic Arterial Infusion
7%
Locoregional Therapy
7%
Postoperative Outcomes
7%
Perioperative Fluids
6%
Hepatocellular Carcinoma Patients
6%
Metallochaperone
6%
Capecitabine
6%
Chemoradiotherapy
6%
Nutrition Care
6%
Enteral nutrition
6%
Surgical Oncology
6%
Mutated Genes
6%
Colorectal Metastases
6%
Response Rate
6%
Hepatic Colorectal Metastases
6%
Gastric Cancer
6%
Odds Ratio
6%
After Surgery
6%
Malnutrition
6%
Oncological Outcomes
6%
Surgical Resection
6%
Human Cancer
6%
Neoadjuvant Chemoradiotherapy (nCRT)
6%
People of Color
6%
Breast Tumor
5%
Green Tea
5%
Metaanalysis
5%
Systematic Meta-analysis
5%
Reporting Item
5%
Consensus Methods
5%
Modified Delphi Method
5%
Hepatic Metastasis
5%
Metastatic Liver Tumor
5%
5-year Survival
5%
Concurrent Chemotherapy
5%
Filtration
5%
Breast Cancer
5%
Gastrointestinal Cancer Surgery
5%
Pancreatic Cancer Cells
5%
Cancer Therapeutics
5%
Spherical Tumor
5%
Absorption Contrast
5%
Tissue Model
5%
Cancer Care
5%
Systemic Chemotherapy
5%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
5%
Fluid Rate
5%
Gastrointestinal Malignancies
5%
Genome Sequencing
5%
Secondary Cytoreductive Surgery
5%
Virtual Tumor Board
5%
Neutrophil-lymphocyte Ratio
5%
Human Colon
5%
Resin Microspheres
5%
Hilar Biliary Stricture
5%
Research Consortium
5%
Myelotoxicity
5%
Bone Marrow Toxicity
5%
Perfusion
5%
Microwave Ablation
5%
University of Michigan
5%
Febrile Response
5%
Chronological Age
5%
Transient Radiation
5%
P53 Reactivators
5%
Nuclear Medicine
5%
Hepatobiliary
5%
Failure Prediction
5%
Vertebral Body
5%
Liver Cancer Treatment
5%
Gastroesophageal Junction
5%
Anastomotic Complications
5%
Leukopenia
5%
Bevacizumab Therapy
5%
Vitamin A
5%
Carotenoids
5%
Esophageal Squamous Cell Carcinoma
5%
Resected Gastric Adenocarcinoma
5%
Cyclooxygenase-1 (COX-1)
5%
Non-surgical Management
5%
Serological Response
5%
Programmed Death-ligand 1 (PD-L1)
5%
Inconvenience
5%
TP53 mutant
5%
Age-independent
5%
Nutrition Support Team
5%
Multicenter Retrospective Cohort Study
5%
Surgical Approach
5%
Hepatic Artery Infusion Pump
5%
TRAM Flap
5%
Perioperative nutrition Care
5%
White People
5%
Breast Cancer Research
5%
Failure to Rescue
5%
Flap Reconstruction
5%
Evaluation of Care
5%
Cancer Xenograft
5%
GATA6
5%
Major Pancreatic Surgery
5%
Patient-derived Cell Line
5%
Non-invasive Imaging
5%
Growth in Vitro
5%
Black Tea Polyphenol
5%
Metabolic Syndrome
5%
Contrast Enhancement
5%
Gastric Metastasis
5%
Cirrhosis
5%
Immunotherapy Therapy
5%
Mentoring Program
5%
Locoregional
5%
Computed Tomographic
5%
B-cell Lymphoma 2 (Bcl-2)
5%
Pharmacokinetic Evaluation
5%
Human Pancreatic Cancer
5%
LigaSure
5%
Hepatitis C
5%
Colon mucosa
5%
Peritoneal Cavity
5%
Patient nutrition
5%
Estrogen Receptor Status
5%
Cancer Cell Growth
5%
Appetite Stimulation
5%
Non-cardia Gastric Cancer
5%
Squamous Cell Carcinoma of the Anus
5%
Anal Squamous Cell Carcinoma
5%
Normal Appendix
5%
Metastatic Gastric Cancer
5%
Tumor Specimens
5%
Acute Phase Response
5%
Training Challenges
5%
Hypercalcemia
5%
Aspirin
5%
P53 Pathway
5%
Tumor Imaging
5%
Adaptor
5%
Echinoderm Microtubule-associated Protein-like 4
5%
Vinorelbine
5%
Computed Tomography Images
5%
Nutrition Screening
5%
SMAD4 Gene
5%
Racial Differences
5%
Anti-apoptotic Proteins
5%
Arachidonic Acid Metabolism
5%
Service Utilization
5%
Adult Humans
5%
Microsomes
5%
Estrogen
5%
Adjuvant Systemic Therapy
5%
Gastric Adenocarcinoma
5%
Stricture
5%
Genetic Drivers
5%
Intraoperative Cholangiogram
5%
Complications of Sepsis
5%
Cancer Inpatients
5%
Biliary Stasis
5%
Comfort Measures
5%
Aberrant Bile Duct
5%
Retrospective Analysis
5%
Albumin-bilirubin Grade
5%
Outcome-volume Relationship
5%
Copper Binding
5%
Tumor Tissue
5%
Surgical Emergency
5%
Systemic Administration
5%
Cancer Drug Discovery
5%
Syndecan-4
5%
Rectal mucosa
5%
Switch Mechanism
5%
Ethnic Minorities
5%
European Society
5%
Green Tea Polyphenols
5%
Radiation Signals
5%
Current Management
5%
Genetic Causes
5%
Repeat Hepatic Resection
5%
Texture Signature
5%
Optical Imaging
5%
Anticancer Candidate
5%
Financial Support
5%
Early Rectal Cancer
5%
Cardia
5%
Cell Cycle Arrest
5%
Extrahepatic Cholangiocarcinoma
5%
Health Practices
5%
Irradiation
5%
Therapeutic Strategies
5%
Giant Hemangioma
5%
Single-center Experience
5%
Hepatic Hemangioma
5%
Thiosemicarbazone
5%
Angiogenic Response
5%
Strong Predictor
5%
Small Molecule Compounds
5%
Hepatic Enzyme Induction
5%
Radiologic
5%
Locally Advanced Breast Cancer
5%
Medicine and Dentistry
Cancer
100%
Disease
84%
Malignant Neoplasm
78%
Oncologist
74%
Surgery
67%
Neoplasm
44%
Overall Survival
43%
Hepatocellular Carcinoma
43%
Symptomatic Treatment
39%
Liver Metastasis
38%
Pancreas Cancer
35%
Awareness
35%
Hepatectomy
35%
Pathologist
34%
Pancreaticoduodenectomy
29%
Metastatic Carcinoma
29%
Stomach Cancer
28%
Colorectal Cancer
27%
Chemoradiation Therapy
27%
Peritoneum Mesothelioma
26%
Chemoradiotherapy
26%
Radiation Therapy
24%
Pancreas Adenocarcinoma
24%
Radioembolization
23%
Metastatic Colorectal Cancer
21%
Systematic Review
20%
Yttrium 90
17%
Common Hepatic Artery
17%
Cholangiocarcinoma
17%
Breast Cancer
16%
Neoadjuvant Therapy
16%
Recurrent Disease
15%
Cardia
15%
Esophagectomy
15%
Gastrointestinal Cancer
15%
Mesothelioma
15%
Odds Ratio
14%
Adjuvant Therapy
14%
Systemic Therapy
13%
Surgical Oncology
12%
Gemcitabine
11%
Clinical Guideline
11%
Neuroendocrine Tumor
11%
Liver Cancer
11%
Pancreatic Surgery
11%
Liver Cirrhosis
11%
Immunotherapy
11%
Cytoreductive Surgery
10%
Adenocarcinoma
10%
Survival Analysis
10%
Survival Rate
10%
Stomach Adenocarcinoma
10%
Ovarian Tumor
10%
Desmoplastic Small Round Cell Tumor
10%
Appendix Tumor
10%
Right Hepatic Artery
10%
Liver Tumor
10%
Socioeconomic Status
10%
Gastrointestinal Surgery
10%
Hazard Ratio
10%
Enteric Feeding
9%
Parenteral Nutrition
9%
Intraarterial Drug Administration
9%
Surgeon
9%
Pancreatectomy
9%
Meta-Analysis
8%
Quality of Life
8%
Local Therapy
8%
Health Care Cost
8%
Cancer Therapy
8%
Programmed Death-Ligand 1
8%
Mastectomy
8%
Rectum Cancer
8%
Colorectal Liver Metastasis
8%
Biopsy
8%
Survival Estimate
7%
Clinical Trial
7%
Neoadjuvant Chemotherapy
7%
Mortality Rate
7%
Pancreatic Ductal Adenocarcinoma
7%
Capecitabine
6%
Microwave Thermotherapy
6%
Patient Care
6%
Adjuvant Chemotherapy
6%
Clinician
6%
Nutritional Status
6%
Surgical Emergency
6%
Microsphere
6%
Cytokine
6%
Esophageal Cancer
6%
Estrogen Receptor
6%
Infection
6%
Intraperitoneal Chemotherapy
5%
Cancer Surgery
5%
Tumor Recurrence
5%
Surgical Approach
5%
Counseling
5%
Retrospective Cohort Study
5%
Univariate Analysis
5%
Injury
5%
Contraindication
5%
Cannabinoid
5%
Hospital Administration
5%
Vermiform Appendix
5%
Acinic Cell Carcinoma
5%
Body of Vertebra
5%
Head Cancer
5%
Carcinomatous Peritonitis
5%
Leukopenia
5%
Sleep
5%
Retinol
5%
Carotenoid
5%
Nivolumab
5%
Attributable Risk
5%
Transverse Rectus Abdominis Musculocutaneous Flap
5%
Primary Tumor
5%
Metabolic Syndrome
5%
Gastrointestinal Stromal Tumor
5%
Bilirubin
5%
Locally Advanced Breast Cancer
5%
Cytokine Release Syndrome
5%
Hypercalcaemia
5%
Squamous Cell Carcinoma
5%
Cancer Research
5%
Bone Marrow Toxicity
5%
Nutrition Screening
5%
Virus Vector
5%
Cost-Effectiveness Analysis
5%
Genome Editing
5%
Bile Duct Malformation
5%
Stricture
5%
Intraductal Papillary Mucinous Tumor
5%
Syndecan 4
5%
Somatics
5%
Clustered Regularly Interspaced Short Palindromic Repeat
5%
Clinical Nutrition
5%
Protein P53
5%
Liver Hemangioma
5%
Hepatic Arterial Infusion
5%
Tumor Xenograft
5%
Monoclonal Antibody B.72.3
5%
Peliosis Hepatis
5%
Gastroesophageal Junction
5%
Venous Thromboembolism
5%
Cholestasis
5%
Metallochaperone
5%
Hepatitis C
5%
Nutrition Physiology
5%
Emergency Medical Technician
5%
Peritoneum Metastasis
5%
Kidney Tumour
5%
Local Excision
5%
Cas9
5%
Diaphragm Hernia
5%
Nephrectomy
5%
Medical Care
5%
Strongyloides
5%
Pseudotumor
5%
Verteporfin
5%
Fibrolamellar Hepatocellular Carcinoma
5%
Anatomy
5%
Cancer Stem Cell
5%
Rectum Carcinoma
5%